United States · FDA National Drug Code directory
FINGOLIMOD
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70377-019_19932889-c03e-7dfb-c6b4-eee88d1fd7be
- Product NDC
- 70377-019
- Form
- CAPSULE
- Composition / generic term
- FINGOLIMOD
- Labeler
- Biocon Pharma Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240328
- Source listing expiry
- 20271231
Source-listed ingredients
- FINGOLIMOD HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (70377-019-11) · 70377-019-11
- 28 CAPSULE in 1 CARTON (70377-019-21) · 70377-019-21
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →